News
Anthem Biosciences shares are expected to make strong listing gains on the back of bumper subscription and strong GMP trends.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback